From the publishers of JADPRO

Bone Protection Resource Center


Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review

Last Updated: Tuesday, July 11, 2023

Data from a systematic review of clinical characteristics, treatment approaches, and prognosis in patients with endometrial carcinoma and bone metastases show that local cytoreductive bone surgery was performed in a median 15.8% (IQR 10.3-43.0) of patients; chemotherapy was administered in a median 55.5% (IQR 41.0-63.9), hormonal therapy in 24.7% (IQR 16.3-36.0), and osteooncologic therapy in 2.7% (IQR 0.0-7.5) of patients; and local radiotherapy was performed in a median 66.7% (IQR 55.6-70.0) of patients.

Journal of Bone Oncology
News & Literature Highlights


Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management

Current Osteoporosis Reports

Updates in Management of Bone Metastatic Disease in Primary Solid Tumors with Systemic Therapies

JAMA Network Open

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy

Journal of the National Comprehensive Cancer Network

Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Annals of Pharmacotherapy

Impact of Extended-Interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Non–Small-Cell Lung Cancer and Small-Cell Lung Cancer Patients With Bone Metastases

JAMA Open Network

Description of Major Osteoporotic Fractures in Women With Invasive Breast Cancer Who Received Endocrine Therapy

JAMA Open Network

Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma

Journal of Bone Oncology

Bone Metastases From Urothelial Carcinoma. The Dark Side of the Moon


Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials

Journal of Clinical Oncology

Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: ASCO-OH (CCO) guideline update